Search
Patexia Research
Case number 2:12-cv-04571

CELGENE CORPORATION v. NATCO PHARMA LIMITED et al > Summary

Court Case Number 2:12-cv-04571

Filing Date Jul 20, 2012

Court New Jersey District Court

Status Unknown

Plaintiff

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
08193219 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Jun 5, 2012
08101599 Pharmaceutical composition containing anti-hypertensive agents Jan 24, 2012
07977357 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione Jul 12, 2011
07968569 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione Jun 28, 2011
07465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Dec 16, 2008
07189740 Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes Mar 13, 2007
06755784 Methods for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated Jun 29, 2004
06561976 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug May 13, 2003
06555554 Isoindolines, method of use, and pharmaceutical compositions Apr 29, 2003
06315720 Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug Nov 13, 2001
06281230 Isoindolines, method of use, and pharmaceutical compositions Aug 28, 2001
06045501 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug Apr 4, 2000
05635517 Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines Jun 3, 1997
Menu